Oregon is a leader in promoting healthcare price transparency with a state-run APCD, Oregon All Payer All Claims Database (APAC), and comprehensive mandatory reporting statues for hospitals and other facilities (see 2017 use case document). Oregon is also experimenting with health delivery and payment reform, directing various state agencies to conduct studies on the feasibility of alternative health care delivery financing and coordinated care models that reward quality over volume of patients.
In the 2018 legislative term, Oregon enacted the “Prescription Drug Price Transparency Act” (HB4005), which is fairly similar to what has become law in a few other states. When the price of a medicine rises more than 10 percent, a drug maker must report the reasons to the Oregon Department of Consumer and Business Services, including information about cost of production, marketing and research. Manufacturers face civil penalties of up to $10,000 per day for failing to comply. In addition to mandating new disclosures by drugmakers and insurers, the new law creates a task force that will develop a strategy for greater transparency across the entire supply chain of pharmaceutical products.
The State Database
The Source tracks state activities impacting healthcare price and competition in both legislation and litigation in a searchable database to help stakeholders at the state level understand their legal and regulatory environment as they make efforts to improve access, quality, and efficiency, and reduce costs in healthcare. We currently cover bills from the 2017-2018 legislative term and key statutes from each state. Search the database for specific bills, statutes or cases by using keyword, key issue category, and/or jurisdiction.